title: Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
authors.forename: J-Y
authors.initials: JY
authors.lastname: Blay
authors.forename: H
authors.initials: H
authors.lastname: El Sayadi
authors.forename: P
authors.initials: P
authors.lastname: Thiesse
authors.forename: J
authors.initials: J
authors.lastname: Garret
authors.forename: I
authors.initials: I
authors.lastname: Ray-Coquard
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004551:Elbow Joint; D005260:Female; D005870:Giant Cell Tumors / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D007592:Joint Diseases / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013586:Synovitis, Pigmented Villonodular / Q000188:drug therapy* / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate